Senators Must Get To The Root Of High Drug Prices
When the Senate Finance Committee opens the next in a series of hearings on high drug prices on Tuesday, the witness panel will be unlike any other since the CEOs of...To view the full article, register now.
Already a subscriber? Click here to view full article